Novo Nordisk
Price
Price
Historical dividends and forecast
Novo Nordisk has so far distributed $1.449 in 2024. The next dividend will be paid on 26.03.2025
CHART BY
Frequently asked questions
What is Novo Nordisk's market capitalization?
What is Novo Nordisk's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Novo Nordisk?
What are the analyst ratings and target price for Novo Nordisk's stock?
What is Novo Nordisk's revenue over the trailing twelve months?
What is the EBITDA for Novo Nordisk?
What is the free cash flow of Novo Nordisk?
How many employees does Novo Nordisk have, and what sector and industry does it belong to?
What is the free float of Novo Nordisk's shares?
Financials
- Market Cap
- $363.60B
- EPS (TTM)
- $2.971
- Free Float
- 3.13B
- P/E ratio (TTM)
- 27.73
- Revenue (TTM)
- $37.84B
- EBITDA (TTM)
- $18.95B
- Free Cashflow (TTM)
- $10.87B
Pricing
- 1D span
- $74.93$103.80
- 52W span
- $73.08$148.39
Analyst Ratings
The price target is $134.07 and the stock is covered by 32 analysts.
Buy
21
Hold
7
Sell
4
Information
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
- Employees
- 63,370
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- DK0062498333
- Primary Ticker
- NOVO B